By using this website you allow us to place cookies on your computer. Please read our Privacy Policy for more details.
Publication Date: March 2005
Publisher: Library of Congress. Congressional Research Service
Author(s):
Research Area: Science and technology
Type:
Abstract:
Among many genetically engineered crops being developed are a number modified to produce pharmaceutical compounds (none yet commercialized). Proponents say such plant-based proteins could be produced more cheaply than by conventional methods and economically benefit farmers. But critics see risks, such as potential environmental, food safety, and trade problems. Among the issues is whether the current system for regulating biotechnology is adequate. This report will be updated if events warrant.